HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Senior Attorney: NAD Fills Regulatory “Void” In Setting Ad Standards

This article was originally published in The Rose Sheet

Executive Summary

NAD decisions reference FDA and Federal Trade Commission regulations, but go a distance on their own to establish standards for advertising claims, senior attorney Kathleen Dunnigan suggests. “What we really do is we fill a void, which is to set advertising standards and to try to get truthful and accurate claims,” she says at FDLI’s annual conference.

You may also be interested in...



Regulatory Action Is Lesser Of Firms’ Worries Amid Class-Action Blitz

Using marketing claims that overstep cosmetic boundaries can land firms in class-action suits that sap resources and drag on for years in today’s litigious climate, attorneys noted at the ACI Legal, Regulatory and Compliance Forum on Cosmetics in New York. Speakers provided examples and tips for staying out of court.

J&J Fights NAD Neutrogena Decision Assailing Sunscreen “Barrier”

In a challenge brought by Coppertone sunscreen products marketer Merck & Co., NAD reviews claims for Neutrogena in print, online and in-store advertising, as well as on packaging for Neutrogena Beach Defense lotion and spray. J&J argues its claim uses same term as FDA’s online “Sun Protection” page.

Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer

Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025.  It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS019009

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel